ABSTRACT-The effect of fluvoxamine, a selective serotonin (5-HT) reuptake inhibitor, was studied in a model of anxiety and/or obsessive compulsive disorder (OCD) in mice. In the anxiety/OCD model, marbleburying behavior, marble-burying was significantly suppressed by fluvoxamine at 30 and 60 mg/kg, p.o. and the monoamine reuptake inhibitor clomipramine, at 60 mg/kg, p.o. No suppressive effect, however, was observed by the selective norepinephrine reuptake inhibitor desipramine at doses from 15 to 60 mg/kg, p.o. Suppressive effects were obtained by the serotonergic anxiolytic buspirone at 30 and 60 mg/kg, p.o. and the benzodiazepine anxiolytic diazepam at 10 mg/kg, p.o. The effect of fluvoxamine on marble-burying was slightly attenuated after repeated administration. On the other hand, both the effects of buspirone and diazepam completely disappeared after repeated administration. Effect of fluvoxamine on the marble-burying was unaffected by the 5-HT2 antagonist ritanserin. However, the 5-HT1A antagonist 
Several years ago, selective serotonin (5-HT) reuptake inhibitors (SSRIs; fluvoxamine, fluoxetine, etc.) were introduced as a clinical therapy for depression, and these drugs have since established their status as effective antidepressants with effects comparable to the more traditionally used tricyclic and tetracyclic antidepressants (1). In addition to the antidepressive effects of SSRIs, clinical reports (2, 3) have suggested that clomipramine, a monoamine reuptake inhibitor that inhibits both norepinephrine (NE) and 5-HT reuptake, and fluvoxamine are also effective in the obsessive compulsive disorder (OCD). It was therefore proposed that malfunctions of 5-HT neurotransmission might be involved in OCD (4) , although the biochemical details of OCD are still unknown.
We have already found that fluvoxamine has suppressive effects on immobility in the depression models of mice, tail-suspension (5) and forced-swimming (6) . However, there is as yet no established screening model for OCD. Recently, however, it is suggested that the marble-burying test might be useful in evaluating anti-OCD drugs (7, 8) . There is a report about the effect of fluvoxamine on marble-burying behavior (9) , but no report about the subchronic effect of fluvoxamine on this model and which 5-HT-receptor subtype mediates its effect.
In the present experiments, therefore, we investigated the acute and subchronic effects of fluvoxamine, other tricyclic antidepressants and the anxiolytics on marbleburying in mice, and we determined whether the effect of fluvoxamine is mediated by 5-HT1A-or 5-HT2-receptor subtypes.
Drugs and animals Drugs used in the present experiments were fluvoxamine maleate (Solvay-Duphar, Weesp, The Netherlands); desipramine hydrochloride, clomipramine hydrochloride and (±)8-hydroxy-2-(di-n-propylamino) tetralin hydrobromide (8-OH-DPAT) (Sigma, St. Louis, MO, USA); buspirone hydrochloride (Bristol-Myers-Squibb Research Institute, Tokyo); diazepam (Nippon Bulk, Osaka); ritanserin and 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl] piperazine hydrobromide (NAN-190) (Research Biochemicals Inc., Natick, MA, USA). Fluvoxamine, desipramine, clomipramine and buspirone were dissolved in purified water, and they were administered orally in a volume of 0.1 ml/ 10 g of body weight. Diazepam was suspended in 0.5010 methylcellulose solution, and it was also administered orally. Ritanserin and NAN-190 were dissolved in 0.101o Tween 80, and 8-OH-DPAT was dissolved in physiological saline; they were injected subcutaneously or intraperitoneally.
Male ICR strain mice weighing 20-30 g (Nihon SLC, Atsugi) were used in each experiment. All animals were housed in the animal rooms (temperature, 20-25C; humidity, 60±5010; light on at 7 a.m.; light off at 7 p.m.) for at least 7 days before the behavioral tests. All experiments were carried out between 10 a.m. and 5 p.m. in a sound-proof behavioral testing room under the same environmental conditions as the animal rooms.
Behavioral tests
All procedures were conducted in accordance with the guiding principles for the care and use of laboratory animals by the Japanese Pharmacological Society and with the guidelines of animal care in our laboratories, as approved by the Meiji Seika Pharmaceutical Research Center committee on animal care and use.
For the marble-burying test, an open cubic transparent plastic box (30 x 30 x 30 cm) was used, and 25 clean glass marbles (20 mm diameter) were evenly spaced 5-cm-apart on sawdust 5-cm-deep. The box was placed on an Animex apparatus (Muromachi Kikai, Tokyo) in a sound-proof box to avoid the circumstantial effect.
Sixty minutes after the administration of each drug (30 min after i.p. injection in the case of 8-OH-DPAT), the animal was placed into the cubic box for 30 min, and the number of marbles left uncovered were counted by the experimenters. At the same time, the total activities of animals during the 30-min burying test were counted by an Animex. The results of the marble-burying test were expressed as the number of marbles covered by sawdust in this paradigm. NAN-190, ritanserin or vehicle was injected subcutaneously 30 min before the test in the combination experiments.
To examine the subchronic effect of fluvoxamine and anxiolytics, the animals were treated in a similar manner to the acute experiments, except that these animals received repeated administrations of fluvoxamine, buspirone, diazepam or vehicle once a day (9-10 a.m.) for 14 days. Marble-burying behavior and total activities of these animals were measured at 1 hr after the administration on the 1st or 14th day. Total activities of animals were counted under the usual condition (without marble or sawdust) in the same apparatus as a separate experi-
ment-Statistical analyses
The Steel multiple range test was used for the statistical analysis of the data of the acute experiment.
The analysis of variance and post-hoc Bonferroni analysis were applied to subchronic experiments and combination experiments with antagonists. The effect of fluvoxamine on marble-burying is shown in Fig. 1 . Marble-burying behavior was significantly suppressed by administrations of 30 and 60 mg/kg, p.o. fluvoxamine (P < 0.01, respectively). The effects of fluvoxamine and other drugs on the marble-burying and total activities during the burying test are summarized in Table 1 . Clomipramine significantly suppressed the marbleburying at the highest dose of 60 mg/kg, p.o. (P<0.05), but its effect was half or less potent than that of fluvoxamine. Both drugs slightly (but not significantly) inhibited the total activities of animals. Unlike these serotonergic antidepressants, desipramine at a dose of 60 mg/kg, p.o. had no effect on the marble-burying. On the other hand, 30 and 60 mg/kg, p.o. buspirone markedly suppressed the marble-burying (P<0.05, P<0.01, respectively). At 3 and 10 mg/kg, i.p., 8-OH-DPAT also markedly suppressed the marble-burying (P < 0. 05, P < 0.01, respectively). Similarly, 10 mg/kg, p.o. diazepam completely suppressed the marble-burying (P<0.01).
These 3 drugs, however, significantly suppressed the total activities during the test at the does effectively suppressing marbleburying.
The effects of NAN-190 and ritanserin on the suppressive effect of fluvoxamine are shown in significant difference among the 4 groups on the total activities during the test (Table 2) .
The subchronic effects of fluvoxamine, buspirone and diazepam on marble-burying and total activities are shown in Table 3 . Furthermore, the subchronic effects of these drugs on total activities at the usual condition are shown in Table 4 . The effect of fluvoxamine on the marble-burying was slightly decreased after repeated administration, because 30 mg/kg, p.o. fluvoxamine showed no effect on the 14th day even though it showed a significant effect on day 1 (see Table 1 ). However, the significant sup- pression of marble-burying was still observed with repeated administration of 60 mg/kg, p.o. fluvoxamine. On the other hand, the profound loss of the effects of buspirone and diazepam were observed after repeated administration. Neither repeated doses of buspirone nor those of diazepam had any effect on the 14th day; nevertheless, these drugs had significant effects on the 1st day (see Table 1 ). Total activities during the test were significantly suppressed by 60 mg/kg, p.o. fluvoxamine (Table 3) ; however, there is no significant suppression of total activities by the same dose at the usual condition (without the marbles or sawdust, Table 4 ). The marble-burying test has been established as a screening method to evaluate anxiolytics (10) . Because recent reports (7, 8) suggest that this behavior is useful as a model of OCD, we examined the effect of fluvoxamine on this behavior. We measured the total activities of animals during the burying test, but it should be noted that the counts of total activities during the test include the movements of burying behavior itself. Therefore, even if a drug selectively suppresses marble-burying, it might show slightly decreased counts of total activities. Furthermore, the counts of total activities were different from the level under the usual condition, because the use of 5 cm of sawdust (distance between the animal and the sensor of the Animex) lowered the counts of the Animex. Actually, the total activities during the test were lower than these under the usual condition (See Tables 3 and 4 ). The typical benzodiazepine anxiolytic diazepam suppressed the marbleburying. Similarly both buspirone and 8-OH-DPAT (partial and full 5-HT1A agonists, respectively) significantly suppressed the marble-burying. Therefore, the marbleburying test might be a reasonable method for screening anxiolytics. Diazepam and buspirone showed significant suppression on the total activities at the doses that suppressed marble-burying; however, the suppression of marble-burying by these drugs are stronger than these on the total activities. Therefore, it is the supposed that not all the suppression of marble-burying is dependent on the suppression of the total activities. Fluvoxamine and clomipramine suppressed marble-burying with the slight (but not significant) suppression of total activities. The slight suppression of total activities may correlate with the suppression of marble-burying, but not locomotion or exploratory behavior, because repeated fluvoxamine administration significantly suppressed both marbleburying and total activities under the present testing conditions, but the same treatment did not affect total activities under the usual condition (no marbles or sawdust). The suppression of marble-burying of fluvoxamine was more potent than that of clomipramine. The effect of fluvoxamine obtained was similar to the data in the previous report (9) on burying-behavior. However, the selective NE reuptake inhibitor desipramine was not effective in this model. We could not detect any anxiolytic effect of fluvoxamine on other anxiety models, i.e., Vogel-type conflict and elevated plus-maze tests in rats and in the light-dark box test in mice (11) . Therefore, these results suggest that the suppression of marble-burying correlate with 5-HT reuptake inhibition. The suppression of marble-burying by fluvoxamine and clomipramine might indicate anti-OCD but not anxiolytic effects of these drugs, because fluvoxamine and clomipramine are effective in treating OCD in clinical studies (12) .
Since fluvoxamine's effect on the marble-burying was antagonized by NAN-190, but was not affected by ritanserin, it is suggested that the 5-HT1A but not the 5-HT2 receptor subtype is involved in the effect of fluvoxamine on marble-burying. The inhibition of firing of serotonergic raphe neurons has been assumed to underlie the effects of anxiolytic drugs (13) , and fluvoxamine has been shown to suppress firing of the raphe nuclei via 5-HT1A-autoreceptor activation (14) . So, it is likely that the 5-HT1A autoreceptor mediates fluvoxamine's suppressive effect on marble-burying, and it is also reasonable to assume that this effect is antagonized by . It has been suggested that postsynaptic 5-HT1A receptors mediate the anxiolytic effect of buspirone but not that of 8-OH-DPAT (15). Therefore, it is possible to assume that fluvoxamine's effects on marble-burying are mediated by postsynaptic 5-HT1A receptors. However, it has been reported that fluvoxamine preferentially increases extracellular 5-HT at the raphe nucleus, rather than at the terminal field (16).
At present, therefore, it is unclear whether fluvoxamine's effect on marble-burying is mediated at the level of the autoreceptor or the postsynaptic 5-HTIA receptor. These specific reductions in marble-burying by 5-HT reuptake inhibitors support that this marble-burying is a useful model for evaluating the clinical potential of anxiolytic/anti-OCD drugs. Repeated fluvoxamine administration slightly attenuated the initial suppression of burying behavior in the marble-burying test. The suppressive effect of fluvoxamine on the marble-burying was likely to be mediated by the 5-HT1A autoreceptor as mentioned above, and this receptor has been shown to be desensitized by repeated administration of a 5-HT1A agonist (17) . Therefore, the complete loss of buspirone's effect on marble-burying after repeated administration may relate to the desensitization of the 5-HTIA autoreceptor. It is not known yet whether the autoreceptor was desensitized by the repeated administration of fluvoxamine. However, it is conceivable that a direct 5-HT1A agonist produces stronger desensitization of autoreceptors than an indirect stimulant. This view is supported by the present demonstration that after repeated administration, fluvoxamine's effect on marbleburying was only slightly attenuated, while that of buspirone was completely attenuated. These lines of evidence suggest moderate desensitization of the 5-HT[A autoreceptor is produced after repeated administration of fluvoxamine.
In conclusion, the results obtained in the present experiment suggest that the 5-HTIA-receptor subtype mediates fluvoxamine's anti-burying action.
